GHK-Cu Research Overview

GHK is a naturally occurring tripeptide with the sequence glycyl-L-histidyl-L-lysine. It has a strong affinity for copper(II) ions, and the resulting complex is written GHK-Cu. The copper coordination is central to how the molecule is studied — GHK and GHK-Cu are not treated as equivalent in the literature.

Researchers study GHK-Cu principally in the context of extracellular matrix biology: the network of collagen, elastin, proteoglycans, and other molecules that gives tissue its structure.

GHK was first described in the early 1970s, isolated from human plasma during work on factors affecting hepatic cell cultures. Subsequent work established that its activity in those systems was associated with copper binding.

Over the following decades GHK-Cu became a standard subject in dermatological and connective tissue research, including formulation work in the cosmetic science literature.

The most studied proposed mechanisms involve copper delivery and redox chemistry. Copper is a cofactor for enzymes including lysyl oxidase, which participates in collagen and elastin cross-linking, and superoxide dismutase, an antioxidant enzyme. Researchers have examined whether GHK-Cu influences these systems in cell and tissue models.

Fibroblast culture studies have measured markers of collagen and glycosaminoglycan production. Gene expression profiling studies have reported broad changes in transcript levels across many pathways in cultured cells; these are descriptive findings about cultured cells, and the physiological significance of such profiles is an open question.

Work has also examined metalloproteinase activity — enzymes that remodel the extracellular matrix — and oxidative stress markers in experimental systems.

Extracellular matrix research — collagen, elastin, and proteoglycan biology in fibroblast and tissue models.

Copper coordination chemistry and copper-dependent enzyme systems.

Gene expression and cellular signaling profiling in cultured human cells.

Skin models — cosmetic science and dermatological research, including formulation and penetration studies.

Oxidative stress research in cell systems.

The great majority of mechanistic findings come from in-vitro fibroblast and tissue-model work, with additional animal studies.

Human evidence exists largely in the cosmetic and dermatological literature, where GHK-Cu-containing topical formulations have been evaluated in generally small studies using appearance-related endpoints. Those studies test a finished formulation under specific conditions; they do not establish the biological mechanisms proposed from cell work.

Controlled clinical evidence for outcomes beyond skin-appearance endpoints is limited.

Cell-culture results with a copper complex are strongly condition-dependent — copper concentration, medium composition, and cell type all influence outcomes.

Human studies in the cosmetic literature are often small, short, and use subjective or semi-quantitative endpoints.

Broad gene expression findings are difficult to interpret mechanistically without targeted follow-up.

The distinction between GHK and GHK-Cu is not consistently maintained across all published reports.

GHK-Cu is a well-defined copper-binding tripeptide complex with a long research history dating to its isolation from human plasma in 1973.

Extracellular matrix biology, copper-dependent enzymes, and cellular signaling are the principal areas of investigation, mostly in cell and tissue models.

Laboratory findings should be distinguished from the narrower and generally small body of human formulation studies.

This page is provided for scientific and educational purposes only. It summarizes published laboratory research and does not constitute medical advice, does not describe any approved therapy, and does not provide instructions for human use of any kind.

SFVLAB supplies this compound strictly as a research-use-only material for laboratory investigation.